AstraZeneca appoints Pam Cheng as EVP of operations and IT

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has appointed Pam Cheng as executive vice president of operations and IT.

She will be responsible for manufacturing operations and supply chain, procurement and information technology globally. Ms Cheng joins from Merck & Co (NYSE: MRK), where she was chief operating officer and then president of MSD China.

Pascal Soriot, chief executive of AstraZeneca, said: “I am delighted to welcome Pam to AstraZeneca at a very exciting time for our business. As our pipeline delivers, we will bring an increasing number of new medicines to patients across the globe over the coming years, including important biological therapies as our product mix shifts. Pam will be able to bring to bear her wealth of experience in manufacturing and supply chain management, as well as her experience in emerging markets, particularly China, a key priority for our company.”